Advanced search
Publication Cover
Ultrastructural Pathology Volume 42, 2018 - Issue 4
Submit an article Journal homepage
134
Views
3
CrossRef citations to date
0
Altmetric
Case Reports

Metastatic TFE3-overexpressing renal clear cell carcinoma with dense granules: a histological, immunohistochemical, and ultrastructural study

Shoujun ChenDepartment of Pathology and Translational Pathobiology, LSU Health Shreveport, Shreveport, LA, USA
,
Elba A. Turbat-HerreraDepartment of Pathology and Translational Pathobiology, LSU Health Shreveport, Shreveport, LA, USA
,
Guillermo A. HerreraDepartment of Pathology and Translational Pathobiology, LSU Health Shreveport, Shreveport, LA, USA
,
Meghna ChadhaDepartment of Radiology, LSU Health Shreveport, Shreveport, LA, USA
,
Rodney E. ShackelfordDepartment of Pathology and Translational Pathobiology, LSU Health Shreveport, Shreveport, LA, USA
&
Eric X. WeiDepartment of Pathology and Translational Pathobiology, LSU Health Shreveport, Shreveport, LA, USACorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-5824-867X
ORCID Icon
Pages 369-375 | Received 15 Mar 2018, Accepted 09 Jul 2018, Published online: 24 Jul 2018

References

  • Herrera GA, Turbat-Herrera EA. Ancillary diagnostic techniques in the evaluation of adult epithelial renal neoplasms: indications, caveats, and pitfalls. Appl Immunohistochem Mol Morphol. 2014;22(2):77–98. doi:10.1097/PAI.0b013e318297d569.
  • Kauffman EC, Ricketts CJ, Rais-Bahrami S, et al. Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol. 2014;11(8):465–475. doi:10.1038/nrurol.2014.162.
  • Thorner PS, Shago M, Marrano P, Shaikh F, Somers GR. TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: report of a case with a TPM3-ALK translocation. Pathol Res Pract. 2016;212(10):937–942. doi:10.1016/j.prp.2016.07.004.
  • Kuroda N, Kawada C, Tamura K, et al. Re-evaluation of histological type by immunohistochemical and genetic study of transcription factors (TFE3 and TFEB) of VHL gene mutation-negative clear cell renal cell carcinoma and other special types of renal tumor. Med Mol Morphol. 2011;44(1):46–51. doi:10.1007/s00795-009-0478-3.
  • Kim JK, Frohnert PP, Hui YS, Barnes LD, Farrow GM, Dousa TP. Enzymes of cyclic 3ʹ,5ʹ-nucleotide metabolism in human renal cortex and renal adenocarcinoma. Kidney Int. 1977;12:172–183.
  • Leary T. Crystalline ester cholesterol and adult cortical renal tumors. Arch Pathol (Chic). 1950;50:151–178.
  • Shipkey FH, Lieberman PH, Foote FW, Stewart FW. ULTRASTRUCTURE OF ALVEOLAR SOFT PART SARCOMA. Cancer. 1964;17:821–830.
  • Mukai M, Iri H, Nakajima T, et al. Alveolar soft-part sarcoma. A review on its histogenesis and further studies based on electron microscopy, immunohistochemistry, and biochemistry. Am J Surg Pathol. 1983;7(7):679–689.
  • Meyer PN, Clark JI, Flanigan RC, Picken MM. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am J Clin Pathol. 2007;128(1):70–79. doi:10.1309/LR5G1VMXPY3G0CUK.
  • Cohen C, McCue PA, Derose PB. Histogenesis of renal cell carcinoma and renal oncocytoma. An immunohistochemical study. Cancer. 1988;62:1946–1951.
  • Shen SS, Truong LD, Scarpelli M, Lopez-Beltran A. Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful?. Arch Pathol Lab Med. 2012;136(4):410–417. doi:10.5858/arpa.2011-0472-RA.
  • Alexa A, Baderca F, Lighezan R, Izvernariu D, Raica M. The diagnostic value of cytokeratins expression in the renal parenchyma tumors. Rom J Morphol Embryol. 2010;51:27–35.
  • Lee C, Park JW, Suh JH, Nam KH, Moon KC. Histologic variations and immunohistochemical features of metastatic clear cell renal cell carcinoma. Korean J Pathol. 2013;47(5):426–432. doi:10.4132/KoreanJPathol.2013.47.5.426.
  • Macher-Goeppinger S, Roth W, Wagener N, et al. Molecular heterogeneity of TFE3 activation in renal cell carcinomas. Mod Pathol. 2012;25(2):308–315. doi:10.1038/modpathol.2011.169.
  • Hua X, Liu X, Ansari DO, Lodish HF. Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev. 1998;12:3084–3095.
  • Hua X, Miller ZA, Wu G, Shi Y, Lodish HF. Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins. Proc Natl Acad Sci U S A. 1999;96:13130–13135.
  • Tian G, Erman B, Ishii H, Gangopadhyay SS, Sen R. Transcriptional activation by ETS and leucine zipper-containing basic helix-loop-helix proteins. Mol Cell Biol. 1999;19:2946–2957.
  • Calcagni A, Kors L, Verschuren E, et al. Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling. Elife. 2016:5. Pii: e17047.doi:10.7554/eLife.17047..
  • Ross H, Argani P. Xp11 translocation renal cell carcinoma. Pathology. 2010;42(4):369–373. doi:10.3109/00313021003767348.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.